➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Express Scripts
Boehringer Ingelheim
Dow
Johnson and Johnson
McKinsey
Colorcon

Last Updated: November 26, 2020

DrugPatentWatch Database Preview

ORENCIA Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Recent Clinical Trials for ORENCIA

Identify potential brand extensions & biosimilar entrants

SponsorPhase
Boston Children’s HospitalPhase 2
University of LeedsPhase 2
St George's, University of LondonPhase 4

See all ORENCIA clinical trials

Recent Litigation for ORENCIA

Identify key patents and potential future biosimilar entrants

District Court Litigation
Case NameDate
Celgene Corporation v. Aurobindo Pharma Limited2018-07-06
CELGENE CORPORATION v. EMCURE PHARMACEUTICALS LTD.2018-06-28
AMGEN INC v. SANDOZ INC.2018-06-26

See all ORENCIA litigation

PTAB Litigation
PetitionerDate
Crescendo Bioscience, Inc2017-04-12

See all ORENCIA litigation

Pharmacology for ORENCIA
Ingredient-typeRecombinant Fusion Proteins
Physiological EffectDecreased Cytokine Activity

Patent Text Search: US Patents for ORENCIA

These patents were identified by searching patent claims

Supplementary Protection Certificates for ORENCIA

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
122017000101 Germany   Start Trial PRODUCT NAME: SARILUMAB; REGISTRATION NO/DATE: EU/1/17/1196 20170623
1590021-0 Sweden   Start Trial PRODUCT NAME: IBRUTINIB ELLER ETT FARMACEUTISKT GODTAGBART SALT DAERAV; REG. NO/DATE: EU/1/14/945 20141023
17C1057 France   Start Trial PRODUCT NAME: SARILUMAB; REGISTRATION NO/DATE: EU/1/17/1196 20170627
601 Finland   Start Trial
>Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
AstraZeneca
Express Scripts
Dow
Johnson and Johnson
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.